SPONSOR
Akeso
Total Trials
6
Recruiting
6
Phases
Phase 3, Phase 2, Phase 1, Phase 1, Phase 2
Conditions studied: Colorectal AdenocarcinomaPancreatic CancerSolid TumorSolid CancerNon-Small Cell Lung CancerAdvanced Solid Tumors
Akeso is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Colorectal Adenocarcinoma, Pancreatic Cancer, Solid Tumor, Solid Cancer.
The trial portfolio spans Phase 3, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Akeso
How many clinical trials has Akeso sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Akeso, of which 6 are actively recruiting participants. These trials cover conditions including Colorectal Adenocarcinoma, Pancreatic Cancer, Solid Tumor. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Akeso research focus on?
Akeso clinical trials span Colorectal Adenocarcinoma, Pancreatic Cancer, Solid Tumor, Solid Cancer, Non-Small Cell Lung Cancer, and additional conditions. The research pipeline includes Phase 3, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Akeso clinical trial?
To participate in a Akeso trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Akeso trials with current recruitment status updated daily.
Clinical Trials by Akeso
NCT06951503 Phase 3
Recruiting
AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
Colorectal Adenocarcinoma
NCT07114315 Phase 2
Recruiting
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
Pancreatic Cancer
NCT06166888 Phase 1
Recruiting
A Study of AK131 in Patients With Advanced Solid Tumors
Solid Tumor
NCT07281326 Phase 1
Recruiting
A Study of AK138D1 in Advanced Malignant Tumors
Solid Cancer
NCT07623356 Phase 1, Phase 2
Recruiting
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
NCT07067567 Phase 1
Recruiting
A Study of AK146D1 for Injection in Advanced Solid Tumors
Advanced Solid Tumors
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology